CD4+ T-cell subsets in intestinal inflammation

Intestinal CD4+ T cells are essential mediators of immune homeostasis and inflammation. Multiple subsets of CD4+ T cells have been described in the intestine, which represents an important site for the generation and regulation of cells involved in immune responses both within and outside of the gastrointestinal tract. Recent advances have furthered our understanding of the biology of such cells in the intestine. Appreciation of the functional roles for effector and regulatory populations in health and disease has revealed potential translational targets for the treatment of intestinal diseases, including inflammatory bowel disease. Furthermore, the role of dietary and microbiota‐derived factors in shaping the intestinal CD4+ T‐cell compartment is becoming increasingly understood. Here, we review recent advances in understanding the multifaceted roles of CD4+ T cells in intestinal immunity.

[1]  Jay K Kolls,et al.  The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. , 2013, Annual review of pathology.

[2]  F. Powrie,et al.  Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23-Driven Chronic Intestinal Inflammation , 2012, Immunity.

[3]  Andrew J. Oler,et al.  The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. , 2012, Immunity.

[4]  Richard Bonneau,et al.  A Validated Regulatory Network for Th17 Cell Specification , 2012, Cell.

[5]  Daniel J. Kuster,et al.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo , 2012, The Journal of experimental medicine.

[6]  J. Weiss,et al.  Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells , 2012, The Journal of experimental medicine.

[7]  D. Roos,et al.  The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. , 2012, Immunity.

[8]  D. Littman,et al.  Small molecule inhibitors of RORγt: Targeting Th17 cells and other applications , 2012, European journal of immunology.

[9]  Burkhard Becher,et al.  IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells , 2012, The Journal of experimental medicine.

[10]  A. Regev,et al.  Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.

[11]  B. Jabri,et al.  A specific role for TLR1 in protective TH17 immunity during mucosal infection , 2012, The Journal of experimental medicine.

[12]  Marc Vandemeulebroecke,et al.  Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial , 2012, Gut.

[13]  Meena Subramanyam,et al.  Risk of natalizumab-associated progressive multifocal leukoencephalopathy. , 2012, The New England journal of medicine.

[14]  D. Jarrossay,et al.  Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β , 2012, Nature.

[15]  A. Rudensky,et al.  Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.

[16]  G. Núñez,et al.  Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine , 2012, The Journal of experimental medicine.

[17]  A. Rudensky,et al.  Extrathymically generated regulatory T cells control mucosal TH2 inflammation , 2012, Nature.

[18]  Sharon K. Ahluwalia,et al.  Peripheral Education of the Immune System by Colonic Commensal Microbiota , 2012 .

[19]  Wei Hu,et al.  Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment. , 2011, Immunity.

[20]  C. Klein,et al.  IL‐10 and IL‐10 receptor defects in humans , 2011, Annals of the New York Academy of Sciences.

[21]  A. Rizzo,et al.  Involvement of interleukin-21 in the regulation of colitis-associated colon cancer , 2011, The Journal of experimental medicine.

[22]  Y. Wan,et al.  An essential role of the transcription factor GATA-3 for the function of regulatory T cells. , 2011, Immunity.

[23]  C. Huttenhower,et al.  The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. , 2011, Cell host & microbe.

[24]  Vineet K. Sharma,et al.  Complete genome sequences of rat and mouse segmented filamentous bacteria, a potent inducer of th17 cell differentiation. , 2011, Cell host & microbe.

[25]  Y. Belkaid,et al.  The role of retinoic acid in tolerance and immunity. , 2011, Immunity.

[26]  T. Chatila,et al.  A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. , 2011, Immunity.

[27]  J. Bluestone,et al.  Control of TH17 cells occurs in the Small Intestine , 2011, Nature.

[28]  A. Hoischen,et al.  STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. , 2011, The New England journal of medicine.

[29]  Hilde Cheroutre,et al.  The light and dark sides of intestinal intraepithelial lymphocytes , 2011, Nature Reviews Immunology.

[30]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[31]  D. Vignali,et al.  Cutting Edge: Human Regulatory T Cells Require IL-35 To Mediate Suppression and Infectious Tolerance , 2011, The Journal of Immunology.

[32]  F. Safavi,et al.  The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF , 2011, Nature Immunology.

[33]  C. Elson,et al.  Th17 Cells Induce Colitis and Promote Th1 Cell Responses through IL-17 Induction of Innate IL-12 and IL-23 Production , 2011, The Journal of Immunology.

[34]  L. Lefrançois,et al.  Regional and mucosal memory T cells , 2011, Nature Immunology.

[35]  B. Becher,et al.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.

[36]  S. Hapfelmeier,et al.  Intestinal bacterial colonization induces mutualistic regulatory T cell responses. , 2011, Immunity.

[37]  Y. Wan,et al.  Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathology , 2011, The Journal of experimental medicine.

[38]  R. Caspi,et al.  Faculty Opinions recommendation of Fate mapping of IL-17-producing T cells in inflammatory responses. , 2011 .

[39]  O. Lantz,et al.  Mucosal-associated invariant T cells: unconventional development and function. , 2011, Trends in immunology.

[40]  J. Mora,et al.  Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases. , 2011, Gastroenterology.

[41]  D. Artis,et al.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 , 2011, Nature Immunology.

[42]  Dan R. Littman,et al.  Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity , 2011, Nature.

[43]  A. Rudensky,et al.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.

[44]  Francis J. Huber,et al.  Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.

[45]  Richard A Flavell,et al.  Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. , 2011, Immunity.

[46]  C. Elson,et al.  Experimental inflammatory bowel disease: insights into the host-microbiota dialog. , 2011, Immunity.

[47]  Y. Belkaid,et al.  Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. , 2011, Immunity.

[48]  T. Waldmann,et al.  Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens , 2011, Nature.

[49]  Werner Müller,et al.  Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. , 2011, Immunity.

[50]  P. Bousso,et al.  Restricted Microbiota and Absence of Cognate TCR Antigen Leads to an Unbalanced Generation of Th17 Cells , 2011, The Journal of Immunology.

[51]  D. Artis,et al.  CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. , 2011, Immunity.

[52]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[53]  L. Diehl,et al.  IL-27 promotes T cell–dependent colitis through multiple mechanisms , 2011, The Journal of experimental medicine.

[54]  R. Panush Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2011 .

[55]  박주홍,et al.  The Toll-Like Receptor 2 pathway Establishes Colonization by a Commensal of the Human Microbiota , 2011 .

[56]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[57]  M. J. Broadhurst,et al.  IL-22+ CD4+ T Cells Are Associated with Therapeutic Trichuris trichiura Infection in an Ulcerative Colitis Patient , 2010, Science Translational Medicine.

[58]  Scott A. Brown,et al.  IL-35-mediated induction of a potent regulatory T cell population , 2010, Nature Immunology.

[59]  Todd Davidson,et al.  Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.

[60]  L. Wheeler,et al.  Effect of &agr;4&bgr;7 blockade on intestinal lymphocyte subsets and lymphoid tissue development , 2010, Inflammatory bowel diseases.

[61]  M. Grisham,et al.  Gut‐associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation , 2010, Annals of the New York Academy of Sciences.

[62]  F. Powrie,et al.  Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.

[63]  T. Macdonald,et al.  Interferon‐gamma‐expressing cells are a major source of interleukin‐21 in inflammatory bowel diseases , 2010, Inflammatory bowel diseases.

[64]  S. Mazmanian,et al.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.

[65]  D. Artis,et al.  Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A , 2010, The Journal of experimental medicine.

[66]  Steffen Jung,et al.  Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria , 2010, Nature Reviews Immunology.

[67]  F. Powrie,et al.  OX40 is required for regulatory T cell–mediated control of colitis , 2010, The Journal of experimental medicine.

[68]  Y. Belkaid,et al.  Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.

[69]  W. Paul,et al.  Differentiation of effector CD4 T cell populations (*). , 2010, Annual review of immunology.

[70]  Dan R. Littman,et al.  Th17 and Regulatory T Cells in Mediating and Restraining Inflammation , 2010, Cell.

[71]  Margarida Saraiva,et al.  The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.

[72]  A. Macpherson,et al.  Immune adaptations that maintain homeostasis with the intestinal microbiota , 2010, Nature Reviews Immunology.

[73]  A. Fischer,et al.  Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2010, The Journal of experimental medicine.

[74]  A. Rudensky,et al.  Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate , 2010, Nature.

[75]  P. Rutgeerts,et al.  Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study , 2010, Inflammatory bowel diseases.

[76]  G. Weinstock,et al.  Enteric defensins are essential regulators of intestinal microbial ecology , 2009, Nature Immunology.

[77]  Johan Van Limbergen,et al.  Common variants at five new loci associated with early-onset inflammatory bowel disease , 2009, Nature Genetics.

[78]  A. Rudensky,et al.  CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner , 2009, Science.

[79]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[80]  Annaïg Lan,et al.  The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. , 2009, Immunity.

[81]  F. Powrie,et al.  Regulatory T cells reinforce intestinal homeostasis. , 2009, Immunity.

[82]  C. Weaver,et al.  Intestinal effector T cells in health and disease. , 2009, Immunity.

[83]  G. Eberl,et al.  The development of intestinal lymphoid tissues at the interface of self and microbiota , 2009, Mucosal Immunology.

[84]  J. Bluestone,et al.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo , 2009, Nature Immunology.

[85]  C. Hunter,et al.  IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis1 , 2009, The Journal of Immunology.

[86]  S. Brand Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease , 2009, Gut.

[87]  L. Bradley Faculty Opinions recommendation of The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. , 2009 .

[88]  N. Cerf-Bensussan,et al.  Innate T cell responses in human gut. , 2009, Seminars in immunology.

[89]  Richard A Flavell,et al.  A protective function for interleukin 17A in T cell–mediated intestinal inflammation , 2009, Nature Immunology.

[90]  M. Neurath,et al.  Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. , 2009, Gastroenterology.

[91]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[92]  F. Powrie,et al.  Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.

[93]  T. Chatila,et al.  A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis1 , 2009, The Journal of Immunology.

[94]  B. Pulendran,et al.  TLR2 dependent induction of vitamin A metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits TH-17 mediated autoimmunity , 2009, Nature Medicine.

[95]  A. Keegan Faculty Opinions recommendation of Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. , 2009 .

[96]  R. D. Hatton,et al.  Contrasting roles for all-trans retinoic acid in TGF-β–mediated induction of Foxp3 and Il10 genes in developing regulatory T cells , 2009, The Journal of experimental medicine.

[97]  T. Mcclanahan,et al.  The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo , 2009, Nature Immunology.

[98]  C. Elson,et al.  Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.

[99]  C. Sasakawa,et al.  Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. , 2009, Immunity.

[100]  B. Becher,et al.  RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. , 2009, Gastroenterology.

[101]  C. Hsieh,et al.  Antigen-specific peripheral shaping of the natural regulatory T cell population , 2008, The Journal of experimental medicine.

[102]  A. Murphy,et al.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.

[103]  T. Okanoue,et al.  Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. , 2008, Biochemical and biophysical research communications.

[104]  C. Dong Regulation and pro‐inflammatory function of interleukin‐17 family cytokines , 2008, Immunological reviews.

[105]  H. Yoshida,et al.  Regulation of immune responses by interleukin‐27 , 2008, Immunological reviews.

[106]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[107]  E. Kremmer,et al.  Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo , 2008, The Journal of experimental medicine.

[108]  J. Berzofsky,et al.  Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. , 2008, Immunity.

[109]  R Balfour Sartor,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[110]  Masahiro Yamamoto,et al.  ATP drives lamina propria TH17 cell differentiation , 2008, Nature.

[111]  R. Kastelein,et al.  Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine , 2008, The Journal of experimental medicine.

[112]  L. Cosmi,et al.  Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor , 2008, The Journal of experimental medicine.

[113]  S. Tangye,et al.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.

[114]  D. Riethmacher,et al.  In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells , 2008, The Journal of experimental medicine.

[115]  F. Powrie,et al.  Dendritic cells in intestinal immune regulation , 2008, Nature Reviews Immunology.

[116]  C. Hunter,et al.  IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. , 2008, International immunology.

[117]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[118]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[119]  R. Broaddus,et al.  Regulation of inflammatory responses by IL-17F , 2008, The Journal of experimental medicine.

[120]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[121]  F. Powrie,et al.  Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis , 2008, Immunity.

[122]  A. Rizzo,et al.  Regulation of gut inflammation and th17 cell response by interleukin-21. , 2008, Gastroenterology.

[123]  S. Brand,et al.  Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL‐22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status , 2008, Inflammatory bowel diseases.

[124]  J. Mora,et al.  Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids. , 2008, Inflammatory bowel diseases.

[125]  R. Xavier,et al.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.

[126]  M. Huber,et al.  IL-27 inhibits the development of regulatory T cells via STAT3. , 2008, International immunology.

[127]  Chen Dong,et al.  T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.

[128]  J. Berzofsky Faculty Opinions recommendation of TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. , 2007 .

[129]  Yue Zhang,et al.  Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner. , 2007, International immunology.

[130]  T. Mcclanahan,et al.  TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology , 2007, Nature Immunology.

[131]  Christophe Benoist,et al.  Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. , 2007, Immunity.

[132]  K. Boyd,et al.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function , 2007, Nature.

[133]  I. McInnes,et al.  IL‐35 is a novel cytokine with therapeutic effects against collagen‐induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells , 2007, European journal of immunology.

[134]  Hua Yu,et al.  Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1 , 2007, The Journal of Immunology.

[135]  D. Levy,et al.  IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.

[136]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[137]  A. Rudensky,et al.  Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3− precursor cells in the absence of interleukin 10 , 2007, Nature Immunology.

[138]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[139]  W. Paul,et al.  Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis , 2007, European journal of immunology.

[140]  T. Mcclanahan,et al.  Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. , 2007, Gastroenterology.

[141]  Y. Wan,et al.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. , 2007, Immunity.

[142]  J. Coombes,et al.  Control of intestinal homeostasis by regulatory T cells and dendritic cells. , 2007, Seminars in immunology.

[143]  C. Eun A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. , 2007 .

[144]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[145]  D. Hommes,et al.  Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn’s disease , 2006, Gut.

[146]  F. Powrie,et al.  Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis1 , 2006, The Journal of Immunology.

[147]  A. Sher,et al.  IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.

[148]  F. Powrie,et al.  Interleukin-23 drives innate and T cell–mediated intestinal inflammation , 2006, The Journal of experimental medicine.

[149]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[150]  M. Neurath,et al.  Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications , 2006, Gut.

[151]  R. Flavell,et al.  Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms , 2006 .

[152]  A. Rudensky,et al.  Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. , 2006, Immunity.

[153]  L. Lefrançois,et al.  Evidence that a significant number of naive T cells enter non‐lymphoid organs as part of a normal migratory pathway , 2006, European journal of immunology.

[154]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[155]  F. Powrie,et al.  Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. , 2006, Immunity.

[156]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[157]  L. Lefrançois,et al.  Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. , 2006, Annual review of immunology.

[158]  R. Flavell,et al.  Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. , 2006, Immunity.

[159]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.

[160]  R. Alon,et al.  Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.

[161]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[162]  R. Coffman,et al.  T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[163]  T. Watts,et al.  TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.

[164]  A. Macpherson,et al.  Interactions between commensal intestinal bacteria and the immune system , 2004, Nature Reviews Immunology.

[165]  P. Mannon,et al.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. , 2004, The Journal of clinical investigation.

[166]  A. Andoh,et al.  Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. , 2004, Clinical immunology.

[167]  F. D. de Sauvage,et al.  IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[168]  D. Hommes,et al.  Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. , 2003, Gastroenterology.

[169]  F. Powrie,et al.  Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1 , 2003, The Journal of Immunology.

[170]  M. Neurath,et al.  CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. , 2003, The Journal of clinical investigation.

[171]  A. Mowat,et al.  Anatomical basis of tolerance and immunity to intestinal antigens , 2003, Nature Reviews Immunology.

[172]  Subrata Ghosh,et al.  Natalizumab for active Crohn's disease. , 2003, The New England journal of medicine.

[173]  武田 篤信 Cutting edge : Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment , 2003 .

[174]  T. Hibi,et al.  Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement , 2002, American Journal of Gastroenterology.

[175]  T. Mcclanahan,et al.  A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.

[176]  S. Szabo,et al.  The Transcription Factor T-bet Regulates Mucosal T Cell Activation in Experimental Colitis and Crohn's Disease , 2002, The Journal of experimental medicine.

[177]  T. Macdonald,et al.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. , 2001, The Journal of clinical investigation.

[178]  A. Sher,et al.  Helicobacter hepaticus-Induced Colitis in Interleukin-10-Deficient Mice: Cytokine Requirements for the Induction and Maintenance of Intestinal Inflammation , 2001, Infection and Immunity.

[179]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[180]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[181]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[182]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[183]  M. Neurath,et al.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo , 2000, Nature Medicine.

[184]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[185]  J M Ward,et al.  Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism , 1998, Infection and Immunity.

[186]  Samir A. Shah,et al.  T Cell–mediated Pathology in Two Models of Experimental Colitis Depends Predominantly on the Interleukin 12/Signal Transducer and Activator of Transcription (Stat)-4 Pathway, but Is Not Conditional on Interferon γ Expression by T Cells , 1998, The Journal of experimental medicine.

[187]  M. Neurath,et al.  Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. , 1996, Journal of immunology.

[188]  M. Leach,et al.  T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice , 1996, The Journal of experimental medicine.

[189]  M. Neurath,et al.  Antibodies to interleukin 12 abrogate established experimental colitis in mice , 1995, The Journal of experimental medicine.

[190]  J. Mcghee,et al.  Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. , 1995, Journal of immunology.

[191]  S. Targan,et al.  Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. , 1995, Journal of immunology.

[192]  R. Coffman,et al.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. , 1994, Immunity.

[193]  R. Testi,et al.  Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes , 1993, European journal of immunology.

[194]  R. Coffman,et al.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.

[195]  J. Watson,et al.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells , 1993, The Journal of experimental medicine.